PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2022 PAVmed Inc Earnings Call Transcript

Mar 15, 2023 / 12:30PM GMT
Release Date Price: €4.23 (-19.08%)
Operator

Welcome to the PAVmed Business Update and Fourth Quarter 2022 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the call over to your host, Michael Parks, Vice President, Investor Relations. Mr. Parks, you may begin.

Michael Parks

Thank you, Jen, and good morning, everyone. Thank you for participating in today's fourth quarter 2022 business update call. The press release announcing this business update and the fourth quarter 2022 financials is available on the PAVmed website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The business update press release and the conference call both include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made.

Factors that could cause results to differ are described in the disclaimer and in our filings with the U.S. Securities and Exchange Commission. For a list and description of these and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot